Ongoing challenge of optimal patient selection for CNS prophylaxis in patients with non-Hodgkin lymphoma

C Y Cheah, John F. Seymour, Michael Dickinson

Research output: Contribution to journalArticle

Abstract

CNS relapse is a devastating and frequently lethal complication in patients with lymphoma, and selecting patients to receive CNS-directed prophylaxis is a common and frequently challenging decision for the clinician. Histologic subtype, anatomic location, molecular and clinical risk factors may all be used to stratify patients for CNS risk. In this paper we focus on these issues and attempt to provide practical guidance for the clinician in selecting which patients with lymphoma may benefit from CNS prophylaxis. 2014 Future Medicine Ltd.
Original languageEnglish
Pages (from-to)189-201
Number of pages13
JournalInternational Journal of Hematologic Oncology
Volume3
Issue number3
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint Dive into the research topics of 'Ongoing challenge of optimal patient selection for CNS prophylaxis in patients with non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this